These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 16537421)
21. CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation. Subramaniam V; Vincent IR; Gardner H; Chan E; Dhamko H; Jothy S Exp Mol Pathol; 2007 Oct; 83(2):207-15. PubMed ID: 17599831 [TBL] [Abstract][Full Text] [Related]
22. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells. Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348 [TBL] [Abstract][Full Text] [Related]
23. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
24. MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection. Blanié S; Gelfi J; Bertagnoli S; Camus-Bouclainville C Virol J; 2010 Mar; 7():56. PubMed ID: 20211013 [TBL] [Abstract][Full Text] [Related]
25. Methods for the Construction of Recombinant Oncolytic Myxoma Viruses. Torres-Domínguez LE; de Matos AL; Rahman MM; McFadden G Methods Mol Biol; 2021; 2225():63-75. PubMed ID: 33108657 [TBL] [Abstract][Full Text] [Related]
26. Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits. Stanford MM; Barrett JW; Gilbert PA; Bankert R; McFadden G J Virol; 2007 Nov; 81(22):12704-8. PubMed ID: 17728229 [TBL] [Abstract][Full Text] [Related]
27. Role of the serine-threonine kinase PAK-1 in myxoma virus replication. Johnston JB; Barrett JW; Chang W; Chung CS; Zeng W; Masters J; Mann M; Wang F; Cao J; McFadden G J Virol; 2003 May; 77(10):5877-88. PubMed ID: 12719581 [TBL] [Abstract][Full Text] [Related]
28. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits. Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL Viruses; 2020 May; 12(5):. PubMed ID: 32397134 [TBL] [Abstract][Full Text] [Related]
29. Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells. Barrett JW; Alston LR; Wang F; Stanford MM; Gilbert PA; Gao X; Jimenez J; Villeneuve D; Forsyth P; McFadden G J Neurovirol; 2007 Dec; 13(6):549-60. PubMed ID: 18097886 [TBL] [Abstract][Full Text] [Related]
30. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Stanford MM; McFadden G Expert Opin Biol Ther; 2007 Sep; 7(9):1415-25. PubMed ID: 17727330 [TBL] [Abstract][Full Text] [Related]
31. Metabolic signatures associated with oncolytic myxoma viral infections. Mahar R; Ragavan M; Chang MC; Hardiman S; Moussatche N; Behar A; Renne R; Merritt ME Sci Rep; 2022 Jul; 12(1):12599. PubMed ID: 35871072 [TBL] [Abstract][Full Text] [Related]
32. Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma. MacNeill AL; Weishaar KM; Séguin B; Powers BE Viruses; 2018 Jul; 10(8):. PubMed ID: 30060548 [TBL] [Abstract][Full Text] [Related]
33. Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells. Istivan TS; Pirogova E; Gan E; Almansour NM; Coloe PJ; Cosic I PLoS One; 2011; 6(9):e24809. PubMed ID: 21949758 [TBL] [Abstract][Full Text] [Related]
34. The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics. Liu J; Wennier S; McFadden G Microbes Infect; 2010 Dec; 12(14-15):1144-52. PubMed ID: 20832500 [TBL] [Abstract][Full Text] [Related]
35. An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function. Nounamo B; Li Y; O'Byrne P; Kearney AM; Khan A; Liu J Virology; 2017 Mar; 503():94-102. PubMed ID: 28157624 [TBL] [Abstract][Full Text] [Related]
36. Myxoma T2 protein as a model for poxvirus TNF receptor homologs. McFadden G; Schreiber M; Sedger L J Neuroimmunol; 1997 Feb; 72(2):119-26. PubMed ID: 9042102 [TBL] [Abstract][Full Text] [Related]
37. Activation of Nippostrongylus brasiliensis infective larvae is regulated by a pathway distinct from the hookworm Ancylostoma caninum. Huang SC; Chan DT; Smyth DJ; Ball G; Gounaris K; Selkirk ME Int J Parasitol; 2010 Dec; 40(14):1619-28. PubMed ID: 20654619 [TBL] [Abstract][Full Text] [Related]
38. Akt signaling pathway: a target for radiosensitizing human malignant glioma. Chautard E; Loubeau G; Tchirkov A; Chassagne J; Vermot-Desroches C; Morel L; Verrelle P Neuro Oncol; 2010 May; 12(5):434-43. PubMed ID: 20406894 [TBL] [Abstract][Full Text] [Related]
39. Peripheral inflammation induces tumor necrosis factor dependent AMPA receptor trafficking and Akt phosphorylation in spinal cord in addition to pain behavior. Choi JI; Svensson CI; Koehrn FJ; Bhuskute A; Sorkin LS Pain; 2010 May; 149(2):243-253. PubMed ID: 20202754 [TBL] [Abstract][Full Text] [Related]
40. Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients. Raimondi V; Vescovini R; Dessena M; Donofrio G; Storti P; Giuliani N Front Immunol; 2024; 15():1483806. PubMed ID: 39539548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]